000			02078 a2200457 4500
005			20250518020904.0
264		0	_c20190408
008			201904s 0 0 eng d
022			_a1643-3750
024	7		_a10.12659/MSM.911579 _2doi
040			_aNLM _beng _cNLM
100	1		_aWang, Qizhang
245	0	0	_aEpidermal Growth Factor Reverses the Inhibitory Effects of the Bisphosphonate, Zoledronic Acid, on Human Oral Keratinocytes and Human Vascular Endothelial Cells In Vitro via the Epidermal Growth Factor Receptor (EGFR)/Akt/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway. _h[electronic resource]
260			_bMedical science monitor : international medical journal of experimental and clinical research _cJan 2019
300			_a700-710 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBisphosphonate-Associated Osteonecrosis of the Jaw _xdrug therapy
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aEndothelial Cells _xdrug effects
650	0	4	_aEpidermal Growth Factor _xmetabolism
650	0	4	_aErbB Receptors _xdrug effects
650	0	4	_aHuman Umbilical Vein Endothelial Cells _xdrug effects
650	0	4	_aHumans
650	0	4	_aKeratinocytes _xdrug effects
650	0	4	_aNeovascularization, Pathologic _xmetabolism
650	0	4	_aNeovascularization, Physiologic _xdrug effects
650	0	4	_aNitric Oxide Synthase Type III _xmetabolism
650	0	4	_aPhosphatidylinositol 3-Kinases _xdrug effects
650	0	4	_aProto-Oncogene Proteins c-akt _xdrug effects
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aZoledronic Acid _xpharmacology
700	1		_aLiu, Jiyuan
700	1		_aGuo, Ting
700	1		_aLiu, Dazhong
700	1		_aPan, Jian
773	0		_tMedical science monitor : international medical journal of experimental and clinical research _gvol. 25 _gp. 700-710
856	4	0	_uhttps://doi.org/10.12659/MSM.911579 _zAvailable from publisher's website
999			_c29286324 _d29286324